Annual CFO
$8.47 B
-$1.25 B-12.86%
31 December 2023
Summary:
Amgen annual cash flow from operations is currently $8.47 billion, with the most recent change of -$1.25 billion (-12.86%) on 31 December 2023. During the last 3 years, it has fallen by -$2.03 billion (-19.30%). AMGN annual CFO is now -25.01% below its all-time high of $11.30 billion, reached on 31 December 2018.AMGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$3.57 B
+$1.11 B+45.22%
30 September 2024
Summary:
Amgen quarterly cash flow from operations is currently $3.57 billion, with the most recent change of +$1.11 billion (+45.22%) on 30 September 2024. Over the past year, it has increased by +$811.00 million (+29.38%). AMGN quarterly CFO is now -13.09% below its all-time high of $4.11 billion, reached on 30 June 2023.AMGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$7.26 B
+$811.00 M+12.58%
30 September 2024
Summary:
Amgen TTM cash flow from operations is currently $7.26 billion, with the most recent change of +$811.00 million (+12.58%) on 30 September 2024. Over the past year, it has dropped by -$3.33 billion (-31.42%). AMGN TTM CFO is now -37.00% below its all-time high of $11.52 billion, reached on 31 March 2018.AMGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMGN Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -12.9% | +29.4% | -31.4% |
3 y3 years | -19.3% | +47.7% | -15.7% |
5 y5 years | -25.0% | +5.7% | -26.2% |
AMGN Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -19.3% | at low | -13.1% | +563.8% | -32.8% | +12.6% |
5 y | 5 years | -25.0% | at low | -13.1% | +563.8% | -33.2% | +12.6% |
alltime | all time | -25.0% | >+9999.0% | -13.1% | >+9999.0% | -37.0% | >+9999.0% |
Amgen Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $3.57 B(+45.2%) | $7.26 B(+12.6%) |
June 2024 | - | $2.46 B(+256.9%) | $6.45 B(-20.4%) |
Mar 2024 | - | $689.00 M(+28.1%) | $8.10 B(-4.4%) |
Dec 2023 | $8.47 B(-12.9%) | $538.00 M(-80.5%) | $8.47 B(-19.9%) |
Sept 2023 | - | $2.76 B(-32.8%) | $10.58 B(-2.0%) |
June 2023 | - | $4.11 B(+286.2%) | $10.80 B(+25.3%) |
Mar 2023 | - | $1.06 B(-59.8%) | $8.62 B(-11.3%) |
Dec 2022 | $9.72 B(+5.0%) | $2.65 B(-11.0%) | $9.72 B(-1.6%) |
Sept 2022 | - | $2.98 B(+54.3%) | $9.88 B(+6.0%) |
June 2022 | - | $1.93 B(-10.8%) | $9.32 B(-0.0%) |
Mar 2022 | - | $2.16 B(-22.9%) | $9.32 B(+0.6%) |
Dec 2021 | $9.26 B(-11.8%) | $2.81 B(+16.1%) | $9.26 B(+7.6%) |
Sept 2021 | - | $2.42 B(+25.2%) | $8.61 B(-9.9%) |
June 2021 | - | $1.93 B(-8.2%) | $9.56 B(-8.7%) |
Mar 2021 | - | $2.10 B(-2.3%) | $10.47 B(-0.3%) |
Dec 2020 | $10.50 B(+14.7%) | $2.15 B(-36.1%) | $10.50 B(-3.3%) |
Sept 2020 | - | $3.37 B(+18.5%) | $10.86 B(-0.1%) |
June 2020 | - | $2.84 B(+33.2%) | $10.87 B(+15.1%) |
Mar 2020 | - | $2.13 B(-15.1%) | $9.44 B(+3.2%) |
Dec 2019 | $9.15 B(-19.0%) | $2.51 B(-25.6%) | $9.15 B(-6.9%) |
Sept 2019 | - | $3.38 B(+138.8%) | $9.83 B(+1.1%) |
June 2019 | - | $1.41 B(-23.4%) | $9.73 B(-6.6%) |
Mar 2019 | - | $1.84 B(-42.2%) | $10.41 B(-7.8%) |
Dec 2018 | $11.30 B(+1.1%) | $3.19 B(-2.4%) | $11.30 B(+1.6%) |
Sept 2018 | - | $3.27 B(+55.7%) | $11.11 B(-1.6%) |
June 2018 | - | $2.10 B(-22.9%) | $11.29 B(-1.9%) |
Mar 2018 | - | $2.73 B(-9.5%) | $11.52 B(+3.1%) |
Dec 2017 | $11.18 B(+7.9%) | $3.01 B(-12.8%) | $11.18 B(-0.8%) |
Sept 2017 | - | $3.45 B(+48.5%) | $11.27 B(+7.6%) |
June 2017 | - | $2.33 B(-2.5%) | $10.47 B(-3.2%) |
Mar 2017 | - | $2.38 B(-23.1%) | $10.82 B(+4.5%) |
Dec 2016 | $10.35 B(+6.4%) | $3.10 B(+16.5%) | $10.35 B(+11.0%) |
Sept 2016 | - | $2.66 B(-0.6%) | $9.33 B(-2.4%) |
June 2016 | - | $2.68 B(+39.8%) | $9.56 B(-6.0%) |
Mar 2016 | - | $1.92 B(-7.6%) | $10.16 B(+4.4%) |
Dec 2015 | $9.73 B(+8.7%) | $2.07 B(-28.3%) | $9.73 B(-7.3%) |
Sept 2015 | - | $2.89 B(-11.9%) | $10.50 B(+1.5%) |
June 2015 | - | $3.28 B(+121.6%) | $10.35 B(+11.4%) |
Mar 2015 | - | $1.48 B(-47.9%) | $9.29 B(+3.8%) |
Dec 2014 | $8.95 B(+42.3%) | $2.84 B(+3.7%) | $8.95 B(+12.7%) |
Sept 2014 | - | $2.74 B(+23.1%) | $7.95 B(+13.3%) |
June 2014 | - | $2.23 B(+95.0%) | $7.01 B(+9.8%) |
Mar 2014 | - | $1.14 B(-37.8%) | $6.38 B(+1.5%) |
Dec 2013 | $6.29 B(+7.0%) | $1.83 B(+1.5%) | $6.29 B(+19.4%) |
Sept 2013 | - | $1.81 B(+12.9%) | $5.27 B(+1.6%) |
June 2013 | - | $1.60 B(+52.5%) | $5.18 B(-13.0%) |
Mar 2013 | - | $1.05 B(+29.2%) | $5.96 B(+1.3%) |
Dec 2012 | $5.88 B(+14.9%) | $812.00 M(-52.9%) | $5.88 B(-11.6%) |
Sept 2012 | - | $1.72 B(-27.5%) | $6.65 B(+12.8%) |
June 2012 | - | $2.38 B(+144.3%) | $5.90 B(+16.6%) |
Mar 2012 | - | $972.00 M(-38.6%) | $5.06 B(-1.1%) |
Dec 2011 | $5.12 B(-11.5%) | $1.58 B(+63.5%) | $5.12 B(-7.6%) |
Sept 2011 | - | $969.00 M(-36.9%) | $5.54 B(-5.7%) |
June 2011 | - | $1.54 B(+49.1%) | $5.88 B(-0.5%) |
Mar 2011 | - | $1.03 B(-48.7%) | $5.90 B(+2.0%) |
Dec 2010 | $5.79 B(-8.7%) | $2.01 B(+54.2%) | $5.79 B(+3.3%) |
Sept 2010 | - | $1.30 B(-16.8%) | $5.60 B(-10.7%) |
June 2010 | - | $1.56 B(+71.3%) | $6.28 B(-1.8%) |
Mar 2010 | - | $913.00 M(-49.9%) | $6.39 B(+0.9%) |
Dec 2009 | $6.34 B(+5.8%) | $1.82 B(-7.7%) | $6.34 B(+7.2%) |
Sept 2009 | - | $1.98 B(+17.6%) | $5.91 B(+11.0%) |
June 2009 | - | $1.68 B(+95.5%) | $5.33 B(+1.1%) |
Mar 2009 | - | $859.00 M(-38.5%) | $5.26 B(-12.1%) |
Dec 2008 | $5.99 B(+10.9%) | $1.40 B(+0.5%) | $5.99 B(-2.2%) |
Sept 2008 | - | $1.39 B(-14.1%) | $6.12 B(-3.1%) |
June 2008 | - | $1.62 B(+2.3%) | $6.32 B(+3.8%) |
Mar 2008 | - | $1.58 B(+3.4%) | $6.09 B(+12.8%) |
Dec 2007 | $5.40 B(+0.2%) | $1.53 B(-3.7%) | $5.40 B(+5.6%) |
Sept 2007 | - | $1.59 B(+14.2%) | $5.11 B(+0.3%) |
June 2007 | - | $1.39 B(+55.7%) | $5.10 B(-0.0%) |
Mar 2007 | - | $893.00 M(-28.1%) | $5.10 B(-5.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2006 | $5.39 B(+9.7%) | $1.24 B(-21.0%) | $5.39 B(+2.1%) |
Sept 2006 | - | $1.57 B(+13.1%) | $5.28 B(+2.5%) |
June 2006 | - | $1.39 B(+17.6%) | $5.14 B(+3.5%) |
Mar 2006 | - | $1.18 B(+4.8%) | $4.97 B(+1.2%) |
Dec 2005 | $4.91 B(+32.8%) | $1.13 B(-21.7%) | $4.91 B(+0.4%) |
Sept 2005 | - | $1.44 B(+18.5%) | $4.89 B(+8.2%) |
June 2005 | - | $1.22 B(+8.4%) | $4.52 B(+2.3%) |
Mar 2005 | - | $1.12 B(+1.2%) | $4.42 B(+19.6%) |
Dec 2004 | $3.70 B(+3.6%) | $1.11 B(+3.4%) | $3.70 B(-2.3%) |
Sept 2004 | - | $1.07 B(-3.8%) | $3.79 B(+12.6%) |
June 2004 | - | $1.11 B(+179.4%) | $3.36 B(+5.5%) |
Mar 2004 | - | $399.00 M(-66.7%) | $3.19 B(-10.7%) |
Dec 2003 | $3.57 B(+58.6%) | $1.20 B(+84.7%) | $3.57 B(+11.8%) |
Sept 2003 | - | $648.50 M(-31.0%) | $3.19 B(+12.1%) |
June 2003 | - | $939.70 M(+20.4%) | $2.84 B(+11.9%) |
Mar 2003 | - | $780.80 M(-4.8%) | $2.54 B(+13.1%) |
Dec 2002 | $2.25 B(+51.9%) | $820.30 M(+169.7%) | $2.25 B(+15.1%) |
Sept 2002 | - | $304.10 M(-52.3%) | $1.95 B(+0.9%) |
June 2002 | - | $637.70 M(+31.0%) | $1.94 B(+17.3%) |
Mar 2002 | - | $486.90 M(-7.3%) | $1.65 B(+11.6%) |
Dec 2001 | $1.48 B(-9.4%) | $525.50 M(+83.1%) | $1.48 B(+11.6%) |
Sept 2001 | - | $287.00 M(-18.5%) | $1.33 B(-19.4%) |
June 2001 | - | $352.30 M(+11.7%) | $1.65 B(-0.6%) |
Mar 2001 | - | $315.40 M(-15.1%) | $1.66 B(+1.3%) |
Dec 2000 | $1.63 B(+52.0%) | $371.70 M(-38.7%) | $1.63 B(+12.4%) |
Sept 2000 | - | $606.60 M(+67.6%) | $1.45 B(+24.7%) |
June 2000 | - | $362.00 M(+23.0%) | $1.17 B(-0.2%) |
Mar 2000 | - | $294.30 M(+53.8%) | $1.17 B(+8.7%) |
Dec 1999 | $1.08 B(+3.2%) | $191.30 M(-40.0%) | $1.08 B(-7.6%) |
Sept 1999 | - | $318.90 M(-12.5%) | $1.16 B(+6.6%) |
June 1999 | - | $364.40 M(+81.6%) | $1.09 B(+15.0%) |
Mar 1999 | - | $200.70 M(-28.3%) | $949.40 M(-8.8%) |
Dec 1998 | $1.04 B(+15.4%) | $280.00 M(+13.6%) | $1.04 B(+4.3%) |
Sept 1998 | - | $246.50 M(+10.9%) | $998.80 M(+5.4%) |
June 1998 | - | $222.20 M(-24.1%) | $948.00 M(-1.6%) |
Mar 1998 | - | $292.80 M(+23.4%) | $963.60 M(+6.7%) |
Dec 1997 | $902.90 M(+9.8%) | $237.30 M(+21.3%) | $902.90 M(-4.2%) |
Sept 1997 | - | $195.70 M(-17.7%) | $942.40 M(+5.0%) |
June 1997 | - | $237.80 M(+2.5%) | $897.20 M(-6.7%) |
Mar 1997 | - | $232.10 M(-16.1%) | $961.40 M(+16.9%) |
Dec 1996 | $822.60 M(+6.4%) | $276.80 M(+83.9%) | $822.60 M(+6.7%) |
Sept 1996 | - | $150.50 M(-50.2%) | $770.80 M(-4.8%) |
June 1996 | - | $302.00 M(+223.7%) | $809.90 M(+14.0%) |
Mar 1996 | - | $93.30 M(-58.5%) | $710.20 M(-8.1%) |
Dec 1995 | $773.20 M(+45.4%) | $225.00 M(+18.7%) | $773.20 M(+5.6%) |
Sept 1995 | - | $189.60 M(-6.3%) | $732.30 M(+8.8%) |
June 1995 | - | $202.30 M(+29.4%) | $673.10 M(+17.8%) |
Mar 1995 | - | $156.30 M(-15.1%) | $571.50 M(+7.4%) |
Dec 1994 | $531.90 M(+22.8%) | $184.10 M(+41.2%) | $531.90 M(-0.7%) |
Sept 1994 | - | $130.40 M(+29.5%) | $535.80 M(-2.6%) |
June 1994 | - | $100.70 M(-13.7%) | $550.20 M(-0.9%) |
Mar 1994 | - | $116.70 M(-37.9%) | $555.40 M(+28.3%) |
Dec 1993 | $433.00 M(+47.9%) | $188.00 M(+29.8%) | $433.00 M(+30.5%) |
Sept 1993 | - | $144.80 M(+36.7%) | $331.80 M(+33.3%) |
June 1993 | - | $105.90 M(-1957.9%) | $248.90 M(+11.4%) |
Mar 1993 | - | -$5.70 M(-106.6%) | $223.50 M(-23.7%) |
Dec 1992 | $292.80 M(+33.3%) | $86.80 M(+40.2%) | $292.80 M(+42.1%) |
Sept 1992 | - | $61.90 M(-23.1%) | $206.00 M(+43.0%) |
June 1992 | - | $80.50 M(+26.6%) | $144.10 M(+126.6%) |
Mar 1992 | - | $63.60 M(-617.1%) | $63.60 M(+371.1%) |
Dec 1991 | $219.70 M(+1527.4%) | - | - |
Mar 1991 | - | -$12.30 M(-64.5%) | $13.50 M(-72.3%) |
Mar 1991 | $13.50 M(-27.8%) | - | - |
Dec 1990 | - | -$34.60 M(-323.2%) | $48.80 M(-48.5%) |
Sept 1990 | - | $15.50 M(-65.5%) | $94.70 M(+48.0%) |
June 1990 | - | $44.90 M(+95.2%) | $64.00 M(+242.2%) |
Mar 1990 | $18.70 M(-416.9%) | $23.00 M(+103.5%) | $18.70 M(-534.9%) |
Dec 1989 | - | $11.30 M(-174.3%) | -$4.30 M(-72.4%) |
Sept 1989 | - | -$15.20 M(+3700.0%) | -$15.60 M(+3800.0%) |
June 1989 | - | -$400.00 K | -$400.00 K |
Mar 1989 | -$5.90 M | - | - |
FAQ
- What is Amgen annual cash flow from operations?
- What is the all time high annual CFO for Amgen?
- What is Amgen annual CFO year-on-year change?
- What is Amgen quarterly cash flow from operations?
- What is the all time high quarterly CFO for Amgen?
- What is Amgen quarterly CFO year-on-year change?
- What is Amgen TTM cash flow from operations?
- What is the all time high TTM CFO for Amgen?
- What is Amgen TTM CFO year-on-year change?
What is Amgen annual cash flow from operations?
The current annual CFO of AMGN is $8.47 B
What is the all time high annual CFO for Amgen?
Amgen all-time high annual cash flow from operations is $11.30 B
What is Amgen annual CFO year-on-year change?
Over the past year, AMGN annual cash flow from operations has changed by -$1.25 B (-12.86%)
What is Amgen quarterly cash flow from operations?
The current quarterly CFO of AMGN is $3.57 B
What is the all time high quarterly CFO for Amgen?
Amgen all-time high quarterly cash flow from operations is $4.11 B
What is Amgen quarterly CFO year-on-year change?
Over the past year, AMGN quarterly cash flow from operations has changed by +$811.00 M (+29.38%)
What is Amgen TTM cash flow from operations?
The current TTM CFO of AMGN is $7.26 B
What is the all time high TTM CFO for Amgen?
Amgen all-time high TTM cash flow from operations is $11.52 B
What is Amgen TTM CFO year-on-year change?
Over the past year, AMGN TTM cash flow from operations has changed by -$3.33 B (-31.42%)